BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24642718)

  • 1. Identification of novel transmembrane proteins in scirrhous-type gastric cancer by the Escherichia coli ampicillin secretion trap (CAST) method: TM9SF3 participates in tumor invasion and serves as a prognostic factor.
    Oo HZ; Sentani K; Sakamoto N; Anami K; Naito Y; Oshima T; Yanagihara K; Oue N; Yasui W
    Pathobiology; 2014; 81(3):138-48. PubMed ID: 24642718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer.
    Oo HZ; Sentani K; Sakamoto N; Anami K; Naito Y; Uraoka N; Oshima T; Yanagihara K; Oue N; Yasui W
    Oncol Rep; 2014 Jul; 32(1):403-10. PubMed ID: 24807047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TSPAN8, identified by Escherichia coli ampicillin secretion trap, is associated with cell growth and invasion in gastric cancer.
    Anami K; Oue N; Noguchi T; Sakamoto N; Sentani K; Hayashi T; Naito Y; Oo HZ; Yasui W
    Gastric Cancer; 2016 Apr; 19(2):370-380. PubMed ID: 25711980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fukutin, identified by the Escherichia coli ampicillin secretion trap (CAST) method, participates in tumor progression in gastric cancer.
    Oo HZ; Sentani K; Mukai S; Hattori T; Shinmei S; Goto K; Sakamoto N; Naito Y; Anami K; Trang PTB; Yanagihara K; Oue N; Yasui W
    Gastric Cancer; 2016 Apr; 19(2):443-452. PubMed ID: 26223471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer.
    Naito Y; Yasuno K; Tagawa H; Sakamoto N; Oue N; Yashiro M; Sentani K; Goto K; Shinmei S; Oo HZ; Yanagihara K; Hirakawa K; Yasui W
    Oncol Rep; 2014 Oct; 32(4):1720-6. PubMed ID: 25051317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype.
    Anami K; Oue N; Noguchi T; Sakamoto N; Sentani K; Hayashi T; Hinoi T; Okajima M; Graff JM; Yasui W
    J Pathol; 2010 Jul; 221(3):275-84. PubMed ID: 20527021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
    Shinmei S; Sentani K; Hayashi T; Sakamoto N; Goto K; Oo HZ; Naito Y; Teishima J; Matsubara A; Oue N; Kuniyasu H; Yasui W
    Urol Oncol; 2014 Aug; 32(6):769-78. PubMed ID: 24968948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion.
    Hayashi T; Oue N; Sakamoto N; Anami K; Oo HZ; Sentani K; Ohara S; Teishima J; Matsubara A; Yasui W
    Pathobiology; 2011; 78(5):277-84. PubMed ID: 21849809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype.
    Oue N; Sentani K; Sakamoto N; Yasui W
    Cancer Sci; 2015 Aug; 106(8):951-8. PubMed ID: 26033320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer.
    Naito Y; Sakamoto N; Oue N; Yashiro M; Sentani K; Yanagihara K; Hirakawa K; Yasui W
    Cancer Sci; 2014 Feb; 105(2):228-35. PubMed ID: 24283360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer.
    Mukai S; Oue N; Oshima T; Mukai R; Tatsumoto Y; Sakamoto N; Sentani K; Tanabe K; Egi H; Hinoi T; Ohdan H; Yasui W
    Ann Surg Oncol; 2017 Feb; 24(2):594-602. PubMed ID: 26832883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asporin activates coordinated invasion of scirrhous gastric cancer and cancer-associated fibroblasts.
    Satoyoshi R; Kuriyama S; Aiba N; Yashiro M; Tanaka M
    Oncogene; 2015 Jan; 34(5):650-60. PubMed ID: 24441039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
    Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
    World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine threonine kinase 11/liver kinase B1 mutation in sporadic scirrhous-type gastric cancer cells.
    Nishimura S; Yashiro M; Sera T; Yamamoto Y; Kushitani Y; Sugimoto A; Kushiyama S; Togano S; Kuroda K; Okuno T; Murakami Y; Ohira M
    Carcinogenesis; 2020 Nov; 41(11):1616-1623. PubMed ID: 32236518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
    Peng W; Wu G; Fan H; Wu J; Feng J
    Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.